TipRanks
JW Pharmaceutical Corporation (KR:001060)
:001060
South Korea Market
001060
JW Pharmaceutical Corporation
RESEARCH TOOLSreports

JW Pharmaceutical Corporation (001060) Cash flow

― Followers

JW Pharmaceutical Corporation Cash Flow

KR:001060's free cash flow for Q2 2026 was ₩40.19B. For the 2026 fiscal year, KR:001060's free cash flow was decreased by ₩33.37B and operating cash flow was ₩42.51B. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
₩ 96.40B₩ 79.39B₩ 87.16B₩ 56.76B₩ 18.12B
Investing Cash Flow
₩ -7.20B₩ 14.08B₩ -63.83B₩ -18.92B₩ -22.87B
Financing Cash Flow
₩ -59.78B₩ -100.19B₩ -41.19B₩ -36.91B₩ 27.20B
End Cash Position
₩ 39.23B₩ 10.43B₩ 15.91B₩ 33.90B₩ 33.37B
Free Cash Flow
₩ 84.62B₩ 51.25B₩ 46.45B₩ 44.41B₩ 5.22B
Currency in KRW

JW Pharmaceutical Corporation Cash Flow